GlassScriptPhysician profile
Beth Folse Lagarde
NPI 1023721982
$1,121.65
in general payments reported to CMS, 2019-2025
13 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Family Health provider received nationally (typical 2025 total: $209).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $666 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $259.90 | 2024 | Aptima |
| Phathom Pharmaceuticals, INC. | $206.58 | 2024 | Voquezna |
| Corium, LLC | $157.19 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $103.67 | 2025 | |
| Genzyme Corporation | $99.18 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $96.98 | 2024 | |
| Ironshore Pharmaceuticals INC. | $42.73 | 2023 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $41.91 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $38.42 | 2023 | |
| Pfizer INC. | $21.94 | 2023 | |
| Supernus Pharmaceuticals, INC. | $20.66 | 2024 | Qelbree |
| Cranial Technologies, INC | $17.37 | 2025 | Doc Band |
| Ironwood Pharmaceuticals, INC | $15.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Lagarde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.